QC
BSX icon

Quent Capital’s Boston Scientific BSX Stock Holding History

Quent Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.3K Sell
1,502
-1,541
-51% -$123K 0.01% 566
2025
Q4 		$290K Sell
3,043
-388
-11% -$38K 0.02% 317
2025
Q3 		$335K Sell
3,431
-24
-0.7% -$2.48K 0.03% 199
2025
Q2 		$371K Buy
3,455
+231
+7% +$23.4K 0.04% 182
2025
Q1 		$325K Sell
3,224
-32
-1% -$3.22K 0.03% 184
2024
Q4 		$291K Buy
3,256
+744
+30% +$65.5K 0.03% 201
2024
Q3 		$210K Sell
2,512
-266
-10% -$21K 0.02% 324
2024
Q2 		$214K Buy
2,778
+52
+2% +$3.81K 0.02% 301
2024
Q1 		$187K Buy
2,726
+88
+3% +$5.66K 0.02% 337
2023
Q4 		$153K Buy
2,638
+21
+0.8% +$1.12K 0.02% 357
2023
Q3 		$138K Buy
2,617
+96
+4% +$5.04K 0.02% 340
2023
Q2 		$136K Buy
2,521
+206
+9% +$10.8K 0.02% 357
2023
Q1 		$116K Buy
2,315
+1,028
+80% +$48.4K 0.02% 386
2022
Q4 		$59.5K Hold
1,287
– – 0.01% 542
2022
Q3 		$50K Buy
1,287
+28
+2% +$1.12K 0.01% 543
2022
Q2 		$47K Hold
1,259
– – 0.01% 532
2022
Q1 		$56K Buy
1,259
+437
+53% +$18.9K 0.01% 557
2021
Q4 		$35K Buy
+822
New +$34.5K 0.01% 629

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quent Capital's BSX Position: Q1 2026 in Review

Quent Capital reduced its Boston Scientific (BSX) stake by 51% in Q1 2026, selling an estimated $123K and leaving 1,502 shares worth $94.3K. The position accounts for 0.01% of the portfolio, ranked #566.

Quent Capital first reported a position in BSX in Q4 2021 and has held it in 18 quarters since. The position peaked at $371K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Quent Capital held 1,502 shares of Boston Scientific worth $94.3K as of Q1 2026.
  • Quent Capital sold 1,541 Boston Scientific shares in Q1 2026, an estimated $123K.
  • Boston Scientific made up 0.01% of Quent Capital's portfolio in Q1 2026, its #566 holding.
  • Quent Capital first reported a position in Boston Scientific in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Boston Scientific position peaked at $371K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.